Biotech

All Articles

Navigator brings up $100M to create brand new autoimmune pipe

.Navigator Medicines has furnished on its own with $100 million in series A funds as the younger bio...

Duality looks for cash money for ADC trials as IPO wave spreads to Asia

.China's Duality Biotherapeutics has submitted (PDF) documentation for a Hong Kong IPO, looking for ...

YolTech sells China legal rights to gene editing and enhancing therapy for $29M

.Four months after Mandarin gene editing company YolTech Rehabs took its cholesterol disease-focused...

Addex sell increases after Indivior provides to $300M for material

.Indivior is picking up a little molecule allosteric modulator created to treat drug make use of con...

Molecular Partners fine-tunes AML trial over 'suboptimal exposure'

.Molecular Partners has identified "suboptimal visibility" to its tetra-specific T-cell engager as t...

Despite combined market, an equity capital revival could be can be found in Europe: PitchBook

.While the biotech investment performance in Europe has slowed rather adhering to a COVID-19 funding...

8 months after a $213M fundraise, genetics publisher Volume helps make cuts

.After raising $213 thousand in 2023-- among the year's biggest private biotech shots-- Tome Bioscie...

BioMarin develops officer crew along with biotech vets-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, firings ...

Biopharma Q2 VC struck highest level given that '22, while M&ampA slowed

.Venture capital financing in to biopharma rose to $9.2 billion all over 215 deals in the second qua...

Bicara, Zenas look for IPOs to press late-phase assets toward market

.Bicara Therapies and also Zenas Biopharma have actually given fresh catalyst to the IPO market with...